Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.45 |
| ▸ | FPR2 | P25090 | 4/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13484484 | 0.89 | MEN1 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13015810 | 0.88 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13484483 | 0.86 | MEN1 (0.55) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13015822 | 0.84 | MEN1 (0.56) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13428310 | 0.81 | USP2 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13428252 | 0.80 | USP2 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL29442119 | 0.80 | USP2 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL3903552 | 0.79 | MEN1 (0.61) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL29593395 | 0.79 | MEN1 (0.61) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL21878599 | 0.79 | MEN1 (0.59) | MEN1BLMKMT2AUSP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029010-A1 | Diaminorhodamine Derivative | Nagano, Tetsuo (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20080108141-A1 | DIAMINORHODAMINE DERIVATIVE | Nagano, Tetsuo (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1000941-B1 | DIAMINORHODAMINE DERIVATIVES | NAGANO TESTUO (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-6469051-B2 | THE XANTHENE COMPOUND REACTS WITH NITRIC OXIDE TO GIVE A TRIAZOLE FLUORESCENT COMPOUND THAT EMITS STRONG FLUORESCENCE BY IRRADIATION WITH EXCITATION LIGHT OF LONG WAVELENGTH | Nagano, Tetsuo (JP) | 2002-10-22 | — | — | US | disclosed |
| US-20010001800-A1 | Diaminorhodamine derivative | Nagano, Tetsuo (JP) | 2001-05-24 | — | — | US | disclosed |
| US-6201134-B1 | NITRIC OXIDE MEASUREMENT | TETSUO NAGANO (JP) | 2001-03-13 | — | — | US | disclosed |
| EP-1000941-A1 | DIAMINORHODAMINE DERIVATIVES | Nagano, Testuo (JP) | 2000-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108141-A1 | DIAMINORHODAMINE DERIVATIVE | NOS2, PRMT1, ARG1 | MEN1 1550/4885BLM 1714/4885KMT2A 1400/4885 |
| US-20010001800-A1 | Diaminorhodamine derivative | ARGLU1, ARG1, NOS1 | MEN1 2750/4885BLM 3539/4885KMT2A 3926/4885 |
| US-20100029010-A1 | Diaminorhodamine Derivative | NOS2, NOS1, NOS3 | MEN1 1689/4885BLM 1698/4885KMT2A 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.